09.02.2013 Views

Enron Corp. - University of California | Office of The President

Enron Corp. - University of California | Office of The President

Enron Corp. - University of California | Office of The President

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(1) Eli Lilly and Other Improper Transactions<br />

540. One example <strong>of</strong> <strong>Enron</strong>'s improper abuse <strong>of</strong> mark-to-market accounting was its<br />

accounting for a demand side energy deal with Eli Lilly (a company <strong>of</strong> which Lay was a board<br />

member), in which <strong>Enron</strong> improperly accelerated $44 million in income.<br />

541. On 2/26/01, <strong>Enron</strong> proudly announced a $1.3 billion, 15-year agreement between Eli<br />

Lilly and EES, a subsidiary <strong>of</strong> <strong>Enron</strong>, in which EES agreed to provide energy and business-related<br />

services to Eli Lilly. What <strong>Enron</strong> improperly failed to disclose however, was that to win the<br />

contract, <strong>Enron</strong> had to pay and invest $168 million up-front, and that <strong>Enron</strong> knew it would lose<br />

money on the deal. <strong>The</strong> contract called for <strong>Enron</strong> to pay Lilly $50 million up-front to get the deal,<br />

spend another $94 million out <strong>of</strong> its own pocket to upgrade Lilly's facilities, and spend another $24<br />

million to hire and train Lilly's employees.<br />

542. Despite the fact that <strong>Enron</strong> managers knew that the Lilly contract would actually lose<br />

money, <strong>Enron</strong> recognized approximately $44 million <strong>of</strong> the energy supply portion <strong>of</strong> the contract as<br />

revenue, by inappropriately employing mark-to-market accounting, in the quarter the deal was<br />

signed. In fact, as <strong>The</strong> Washington Post reported on 2/18/02:<br />

Eli Lilly and Co., the Indianapolis pharmaceutical manufacturer, signed a $1.3<br />

billion contract in February 2001 turning all its energy requirements over to <strong>Enron</strong><br />

for 15 years. But <strong>Enron</strong> paid Eli Lilly $50 million upfront to win the deal, according<br />

to a former senior executive <strong>of</strong> <strong>Enron</strong>.<br />

Eli Lilly spokesman Ed West confirmed that <strong>Enron</strong> had made an advance<br />

payment but would not disclose the amount for business confidentiality reasons.<br />

"We looked at it as <strong>Enron</strong> backing up their words with cash," he said.<br />

Such upfront payments were not unusual, said Glenn Dickson, a former<br />

EES director <strong>of</strong> asset operations. "It was fairly common on the really big deals to<br />

pay the customer, to lose money, in effect, on the contract, whether you were<br />

paying the customer or losing money you were charging less than it really cost."<br />

- 369 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!